Implementation of Telerehabilitation In Support of HOme-based Physical Exercise for Heart Failure
ITISHOPE4HF
1 other identifier
interventional
61
1 country
1
Brief Summary
ITISHOPE4HF is a randomized controlled trial of telerehabilitation in a heart failure population. The goal is to evaluate if a home-based telerehabilitation project can increase physical activity in heart failure patients. Patients will be provided telerehabilitation or advice on physical activity (standard care).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 30, 2017
CompletedStudy Start
First participant enrolled
June 8, 2017
CompletedFirst Posted
Study publicly available on registry
June 12, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2021
CompletedApril 14, 2022
April 1, 2022
3.7 years
May 30, 2017
April 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Improvement in long-term physical activity.
Change in physical activity between intervention and control group measured throughout the study with Actigraph activity trackers from baseline to 2 years.
2 years
Secondary Outcomes (8)
Changes in cardiac structure and function.
2 years.
Change in physical fitness.
2 years
Effects on renal function.
2 years.
Long-term effects on cardiovascular risk factors.
2 years.
Effects on endothelial function.
2 years.
- +3 more secondary outcomes
Other Outcomes (11)
Differences in heart failure presentation associated with co-morbid chronic kidney disease.
Baseline.
The association of cardiac fibrosis with cardiorenal syndrome
Baseline
Feasibility of telerehabilitation
6 months.
- +8 more other outcomes
Study Arms (2)
Telerehabilitation
EXPERIMENTALIn addition to optimal medical treatment: 3 months of twice weekly group-based telerehabilitation through a video-conferencing on a tablet platform. In addition access to instruction videos for further self-training through the same platform and throughout the whole 2-year period. Electronic devices to trace activity.
Standard care
NO INTERVENTIONIn addition to optimal medical treatment: Advice on physical activity. Electronic devices to trace activity.
Interventions
Activity trackers. Mio Slice is worn through the whole study. Actigraph is worn for one week, at 4 different timepoints through the study.
Eligibility Criteria
You may qualify if:
- Heart failure (HFpEF or HFrEF) according to European guidelines.
- Moderate or severe signs and symptoms of heart failure (NYHA II-III) in the 6 months prior to enrolment.
- N-terminal pro brain natriuretic peptide (NT-proBNP) \> 300 pmol/L.
- Stable (\> 4 weeks) medical therapy for risk factor control.
- Capability to provide signed, informed, written consent.
You may not qualify if:
- Attendance at a rehabilitation program in the 6 months prior to enrolment.
- Non-heart failure causes of heart failure symptoms (significant valvular disease, coronary disease available for revascularization, uncontrolled hypertension, arrhythmia).
- severe or very severe pulmonary disease (eg. COPD GOLD III-IV).
- presence of conditions which might prevent patients from safely exercising at home.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Helse Nord-Trøndelag HFlead
- Norwegian University of Science and Technologycollaborator
- St. Olavs Hospitalcollaborator
Study Sites (1)
St. Olav University Hospital
Trondheim, 7491, Norway
Related Publications (2)
Lundgren KM, Langlo KAR, Salvesen O, Aspvik NP, Mo R, Ellingsen O, Vesterbekkmo E, Zanaboni P, Dalen H, Aksetoy IA. Exercise-Based Telerehabilitation for Heart Failure Patients Declining Outpatient Rehabilitation-A Randomized Controlled Trial. Med Sci Sports Exerc. 2025 Mar 1;57(3):449-460. doi: 10.1249/MSS.0000000000003590. Epub 2024 Nov 6.
PMID: 39501477DERIVEDLundgren KM, Langlo KAR, Salvesen O, Zanaboni P, Cittanti E, Mo R, Ellingsen O, Dalen H, Aksetoy IA. Feasibility of telerehabilitation for heart failure patients inaccessible for outpatient rehabilitation. ESC Heart Fail. 2023 Aug;10(4):2406-2417. doi: 10.1002/ehf2.14405. Epub 2023 May 23.
PMID: 37221704DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Havard Dalen, MD, PhD
Norwegian University of Science and Tehnology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Group assignment is not masked at performance tests. Group assignment is masked to the echo/MRI technician, and for investigators interpreting the recordings. Masking is not relevant for laboratory analysis.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 30, 2017
First Posted
June 12, 2017
Study Start
June 8, 2017
Primary Completion
February 28, 2021
Study Completion
February 28, 2021
Last Updated
April 14, 2022
Record last verified: 2022-04